Spots Global Cancer Trial Database for Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC
Official Title: Phase II, Open Label, Single Arm Study of the Efficacy and Safety of Crizotinib in East Asian Patients With Advanced ALK-Negative NSCLC Harboring a Translocation or Inversion Involving the c-ROS Oncogene (ROS1) Locus
Study ID: NCT01945021
Interventions
Study Description
Brief Summary: To assess treatment effectiveness and safety of oral crizotinib administered to East Asian patients with Advanced Non-Small Cell Lung Cancer (NSCLC) that is confirmed to be positive for a ROS1 positive gene mutation (translocation or inversion) and confirmed negative for an ALK mutation
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Affiliated Hospital of Anhui Medical University, Department of Medical Oncology, Hefei, Anhui, China
Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Chaoyang District, Beijing, China
The Military General Hospital of Beijing PLA / Medical Oncology Dept., Dongcheng District, Beijing, China
307 Hospital of PLA/Department of Lung Cancer, Fengtai District, Beijing, China
Beijing Cancer Hospital, Department of Thoracic Oncology, Haidian District, Beijing, China
Chinese PLA General Hospital, Haidian District, Beijing, China
Beijing Chest Hospital, Tongzhou District, Beijing, China
Respiration department,the First Affiliated Hospital of Third Military Medical University, PLA, Shapingba District, Chongqing, China
Fujian Province Oncology Hospital, Fuzhou, Fujian, China
SUN Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong, China
Guangdong General Hospital, Guangzhou, Guangdong, China
Hunan Provincial Tumor Hospital/Division of Oncology, Changsha, Hunan, China
Department of Oncology, Jilin Provincial Cancer Hospital, Changchun, Jilin, China
The affiliated hospital of medical college Qingdao University / Medical oncology department, Qingdao, Shandong, China
Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai, Shanghai, China
Shanghai Chest Hospital/Lung cancer clinical center, Shanghai, Shanghai, China
Shanghai Pulmonary Hospital, Shanghai, Shanghai, China
Zhongshan Hospital Fudan University / Respiratory Department, Xuhui District, Shanghai, China
Oncology Department, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, Chengdu, Sichuan, China
Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Hexi District, Tianjin, China
The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, Center for Oncology, Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan
Aichi Cancer Center Hospital, Aichi, , Japan
National Cancer Center Hospital East, Chiba, , Japan
NHO Shikoku Cancer Center, Ehime, , Japan
NHO Kyushu Cancer Center, Fukuoka, , Japan
Hyogo Cancer Center, Hyogo, , Japan
Tohoku University Hospital, Miyagi, , Japan
Kinki University Hospital, Osaka, , Japan
Osaka City General Hospital, Osaka, , Japan
Cancer Institute Hospital of JFCR, Tokyo, , Japan
National Cancer Center Hospital, Tokyo, , Japan
Asan Medical Center, Seoul, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Yonsei University, Severance Hospital, Seoul, , Korea, Republic of
Taichung Veterans General Hospital, Taichung, , Taiwan
National Cheng Kung University Hospital, Tainan, , Taiwan
National Taiwan University Hospital, Taipei, , Taiwan
Taipei Veterans General Hospital, Taipei, , Taiwan
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
